Breaking News: NutraLife Biosciences (NLBS) Announces New Phytocannabinoid Rich (PCR Pure) Water Enhancing Product Line | Financial Buzz

Breaking News: NutraLife Biosciences (NLBS) Announces New Phytocannabinoid Rich (PCR Pure) Water Enhancing Product Line

NutraLife Biosciences, Inc. (OTCQB: NLBS) to launch a new line of Phytocannabinoid rich (PCR) water enhancing drops under its new in-house brand PCR Pure.  NutraLife’s new CBD water enhancers will initially be available in four flavors: strawberry, grape, coconut and watermelon. Each 2 oz. bottle will contain 15 servings and have 20 mg per serving or 300 mg per bottle of PCR hemp extract.  The new water enhancers are infused with the extract and can be added to water or other beverages to help support overall health and wellness. 

NutraLife’s water enhancers will be manufactured at its Coconut Creek facility in accordance with Good Manufacturing Practices (GMP) under the direction of Edgar Ward, the Company’s Chief Executive Officer. NutraLife’s products are tested for potency and purity by its in-house laboratory chemists. The Company’s products also undergo third-party testing to ensure they do not contain contaminants such as heavy metals, pesticides, and solvents. 

NutraLife manufactures and distributes thirteen different core formulations which it modifies to meet the specifications of its private label customers. The Company provides approximately 50 different variations of its core formulations. In addition to NutraLife’s CBD water enhancers, NutraLife’s products include CBD infused oral sprays, tinctures, pet drops, pain balms, face creams, and nutraceutical oral spray products for daily health and wellness uses.

NutraLife’s CBD water enhancers are designed to provide a convenient daily dose of Phytocannabinoid rich hemp extract for today’s on the go lifestyle. NutraLife’s water enhancing drops will be coming soon to online retailers as well as the Company’s website at PCRPure.com.

About the Company

NutraLife Biosciences, Inc. operates a multifaceted life sciences company. For more than 6 years the Company has manufactured and distributed private label and branded nutraceutical and wellness products. The Company launched its hemp-based CBD products in 2017. Through its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., NutraLife provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction and processing. 

Sponsored Content Release. Click for Full Disclosure

2 Comments
  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For nutralife biosciences inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated four thousand dollars by meridian ventures. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.